Prothena Corp Public (PRTA) Current Deferred Revenue (2021 - 2026)

Prothena Corp Public's Current Deferred Revenue history runs 6 years deep, the most recent figure standing at $1.6 million for Q1 2026.

• In Q1 2026, Current Deferred Revenue fell 82.84% year-over-year to $1.6 million; the TTM figure through Mar 2026 stood at $1.6 million (down 82.84% YoY), while the FY2025 annual figure was $2.7 million, down 69.9% from the prior year.
• Current Deferred Revenue was $1.6 million for Q1 2026 at Prothena Corp Public, down from $2.7 million in the prior quarter.
• In the past five years, Current Deferred Revenue ranged from a high of $109.5 million in Q1 2022 to a low of $316000.0 in Q3 2023.
• Historically, Current Deferred Revenue has averaged $28.9 million across 5 years, with a median of $9.4 million in 2023.
• The sharpest annual moves came in 2023 and 2024: Current Deferred Revenue plunged 96.73% in 2023, then surged 2684.81% in 2024.
• A 5-year view of Current Deferred Revenue shows it stood at $11.4 million in 2022, then plunged by 97.24% to $316000.0 in 2023, then soared by 2700.63% to $8.8 million in 2024, then slumped by 69.9% to $2.7 million in 2025, then slumped by 38.81% to $1.6 million in 2026.
• The last three Current Deferred Revenue figures came in at $1.6 million (Q1 2026), $2.7 million (Q4 2025), and $2.7 million (Q3 2025), per Business Quant data.